Skip to content

Clinical trials

Completed Uterine Cervical Neoplasms trials in Peru

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Status: Completed Country / region: Peru Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20081
20111
20181
20202
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University2
Merck Sharp & Dohme LLC2
Eli Lilly and Company1
GlaxoSmithKline1
Gynecologic Oncology Group1
Hoffmann-La Roche1
International Atomic Energy Agency1
Preventive Oncology International, Inc.1
Queensland Centre for Gynaecological Cancer1
Seagen, a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms12
Papillomavirus Infections2
Adenocarcinoma1
Carcinoma1
HIV Infections1
Neoplasms1
Uterine Cervical Dysplasia1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.